Research Article
Renal Kallikrein Activation and Renoprotection after Dual Blockade of Renin-Angiotensin System in Diet-Induced Diabetic Nephropathy
Table 2
Expression of kallikrein 1 in renal tissue.
| |||||||||||||||||||||||||||
Group 1, normal control group; group 2, diabetic nephropathy control group; group 3, benazepril (10 mg/kg/d); group 4, irbesartan (30 mg/kg/d); and group 5, benazepril (10 mg/kg/d) & irbesartan (30 mg/kg/d); and compared with group 1, *; compared with group 2, #; compared with group 3, ◆; compared with group 4, ▼. |